Updated Jul 16, 2026
Bozic Carmen has filed 7 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $11.31M.

Carmen Bozic is an executive at Vertex Pharmaceuticals Inc., serving as Executive Vice President and Chief Medical Officer (CMO). In this role, she oversees Vertex's clinical development and medical affairs, guiding strategy for the company’s pipeline including cystic fibrosis therapies and other programs within Vertex’s portfolio.
| Role | EVP and CMO |
|---|---|
| Notability | 40/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-30 | VRTX | VERTEX PHARMACEUTICALS INC / MA | S — Open-market sale | 596 | $482.50 | $288K |
| 2026-06-23 | VRTX | VERTEX PHARMACEUTICALS INC / MA | S — Open-market sale | 1.0K | $462.17 | $471K |
| 2026-06-17 | VRTX | VERTEX PHARMACEUTICALS INC / MA | S — Open-market sale | 4.1K | $450.00 | $1.83M |
| 2026-06-09 | VRTX | VERTEX PHARMACEUTICALS INC / MA | S — Open-market sale | 1.7K | $450.00 | $785K |
| 2026-06-02 | VRTX | VERTEX PHARMACEUTICALS INC / MA | S — Open-market sale | 2.0K | $450.00 | $888K |
| 2026-05-19 | VRTX | VERTEX PHARMACEUTICALS INC / MA | S — Open-market sale | 1.4K | $453.45 | $614K |
| 2026-05-14 | VRTX | VERTEX PHARMACEUTICALS INC / MA | S — Open-market sale | 7.0K | $450.00 | $3.14M |
| 2026-03-31 | VRTX | VERTEX PHARMACEUTICALS INC / MA | S — Open-market sale [10b5-1] | 2.3K | $450.95 | $1.05M |
| 2026-03-17 | VRTX | VERTEX PHARMACEUTICALS INC / MA | S — Open-market sale [10b5-1] | 2.3K | $481.79 | $1.12M |
| 2026-03-03 | VRTX | VERTEX PHARMACEUTICALS INC / MA | S — Open-market sale [10b5-1] | 2.3K | $480.31 | $1.12M |
| 2026-02-26 | VRTX | VERTEX PHARMACEUTICALS INC / MA | F — Tax withholding / forfeiture | 1.5K | $485.11 | $705K |
| 2026-02-19 | VRTX | VERTEX PHARMACEUTICALS INC / MA | F — Tax withholding / forfeiture | 1.9K | $483.75 | $925K |
| 2026-02-19 | VRTX | VERTEX PHARMACEUTICALS INC / MA | A — Grant or award | 5.4K | $0.00 | |
| 2026-02-18 | VRTX | VERTEX PHARMACEUTICALS INC / MA | F — Tax withholding / forfeiture | 3.8K | $487.76 | $1.86M |
| 2026-02-12 | VRTX | VERTEX PHARMACEUTICALS INC / MA | F — Tax withholding / forfeiture | 2.1K | $468.41 | $1.00M |
| 2026-01-26 | VRTX | VERTEX PHARMACEUTICALS INC / MA | A — Grant or award | 3.5K | $0.00 | |
| 2026-01-26 | VRTX | VERTEX PHARMACEUTICALS INC / MA | A — Grant or award | 7.9K | $0.00 |
Carmen Bozic is an executive at Vertex Pharmaceuticals Inc., serving as Executive Vice President and Chief Medical Officer (CMO). In this role, she oversees Vertex's clinical development and medical affairs, guiding strategy for the company’s pipeline including cystic fibrosis therapies and other programs within Vertex’s portfolio.…
7 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 10 open-market sales ($11.31M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Bozic Carmen profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.